doxorubicin hydrochloride has been researched along with paclitaxel in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (6.90) | 29.6817 |
2010's | 21 (72.41) | 24.3611 |
2020's | 6 (20.69) | 2.80 |
Authors | Studies |
---|---|
Ando, M; Bai, J; Bai, L; Bai, Y; Deng, Q; Hasegawa, T; Hirose, K; Kataoka, T; Koyanagi, R; Nagai, K; Sakai, J; Tsukumo, Y; Wang, J; Wang, L; Xing, F; Xue, H; Zhang, S; Zhao, M | 1 |
Baasner, S; Böhm, KJ; Gerlach, M; Günther, EG; Müller, K; Prinz, H; Schmidt, P; Unger, E; Zuse, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Agrawal, SK; Rani, R; Roy, P; Saxena, AK; Singh, J; Sondhi, SM | 1 |
Baasner, S; Böhm, KJ; Gerlach, M; Günther, EG; Müller, K; Nickel, HC; Prinz, H; Schmidt, P; Unger, E | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Cao, R; Chen, Z; Peng, W; Ren, Z; Shi, B; Song, H; Yi, W; Yu, L | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cao, R; Chen, Z; Fan, W; Guo, L; Ma, Q; Shi, B; Song, H; Sun, J | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Bedi, PM; Budhiraja, A; Gupta, MK; Kaur, C; Nepali, K; Saxena, AK; Sharma, S | 1 |
Cao, D; Chen, L; Li, L; Liu, L; Ma, L; Tang, M; Wang, F; Wang, G; Wang, J; Wen, J; Wu, W; Xiang, M; Xiang, W; Yang, J; Yang, Z; You, J; Zhang, R; Zhu, J | 1 |
Guo, YX; Hu, XY; Kang, YQ; Lee, KH; Li, RJ; Lin, ZM; Lou, HX; Morris-Natschke, SL; Wang, S; Wu, JY; Yuan, HQ; Zhang, JZ; Zhou, JC; Zhu, RX | 1 |
Bi, C; Fu, H; Li, Y; Shao, R; Song, D; Su, F; Tang, S; Wang, S; Zhang, C | 1 |
Bai, P; Cao, D; Chen, L; Lei, L; Liu, Y; Ma, B; Ma, L; Tang, M; Wang, C; Wang, F; Wang, T; Wang, X; Xu, B; Yan, W; Yang, T; Yang, Z; Zhou, Y | 1 |
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Xie, F; Yuan, HQ; Zheng, HB | 1 |
Hu, QW; Li, L; Lou, HX; Niu, HM; Sun, B; Tang, H; Yuan, HQ; Zheng, HB | 1 |
Cao, D; Chen, L; Chen, Y; He, L; Li, D; Shao, M; Shen, M; Wang, F; Wang, T; Yan, W; Yang, Z; Zhou, Y | 1 |
Cho, WJ; Han, J; Jin, Y; Khadka, DB; Kwon, Y; Park, S | 1 |
Bai, C; Chen, J; Chen, Y; Chong, C; Ding, Y; Gao, Y; Geng, Y; Li, J; Wang, M; Wu, L; Yu, J; Zhang, Q | 1 |
Bai, P; Chen, L; Hu, M; Li, Y; Tang, M; Yan, W; Yang, J; Yang, Z | 1 |
Bi, Y; Li, W; Ma, C; Shuai, W; Sun, H; Xu, F; Xu, J; Xu, S; Yao, H; Zhu, Z | 1 |
Dong, JY; Huang, G; Li, SS; Meng, QQ; Zhang, QJ; Zhao, HR; Zhu, BQ | 1 |
Ji, A; Li, L; Li, X; Liu, J; Liu, Z; Lou, H; Qian, L; Qiao, Y; Sun, Y; Wang, X; Xu, Y; Zhao, X | 1 |
Chen, ZS; Li, W; Liu, Y; Shuai, W; Tan, Y; Xu, J; Xu, S; Yang, DH; Yang, L; Yao, H; Zheng, T; Zhu, H; Zhu, Z | 1 |
Han, L; Huang, X; Jin, X; Li, X; Liang, B; Ouyang, F; Xu, Y; Yan, J; Zhan, M; Zhang, Q | 1 |
Bai, P; Chen, L; Fu, S; Han, K; He, W; Li, J; Li, Y; Liu, J; Liu, Y; Shi, M; Tang, M; Xie, L; Yan, W; Yang, J; Yang, Z; Ye, H; Zhang, C; Zhu, Z | 1 |
Cai, Z; Ghaleb, H; Huang, W; Jiang, Y; Liu, Y; Qian, H; Qiu, Q; Shi, W; Yin, Z; Zhang, P; Zhou, J; Zou, F | 1 |
Li, X; Lin, H; OuYang, F; Pang, Y; Yan, J; Zhang, W; Zhou, J | 1 |
29 other study(ies) available for doxorubicin hydrochloride and paclitaxel
Article | Year |
---|---|
Bioactive guaianolides from siyekucai (Ixeris chinensis).
Topics: Antineoplastic Agents, Phytogenic; Asteraceae; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Inhibitory Concentration 50; Intercellular Adhesion Molecule-1; Molecular Structure; Plants, Medicinal; Sesquiterpenes, Guaiane; Tumor Cells, Cultured | 2006 |
Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Topics: Anthracenes; Cell Cycle; Cell Line, Tumor; Colchicine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Naphthalenes; Nocodazole; Podophyllotoxin; Structure-Activity Relationship; Thiophenes; Tubulin; Tubulin Modulators | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Microwaves; Neoplasms; Ovarian Neoplasms | 2010 |
Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety.
Topics: Anthracenes; Antineoplastic Agents; Benzylidene Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Protein Multimerization; Protein Structure, Quaternary; Tubulin | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
Topics: Animals; Antineoplastic Agents; Binding Sites; Carbolines; Cattle; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Solubility; Stereoisomerism; Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis and biological evaluation of 1,9-disubstituted β-carbolines as potent DNA intercalating and cytotoxic agents.
Topics: Antineoplastic Agents; Carbolines; Cell Line, Tumor; Cytotoxins; DNA; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Intercalating Agents; Neoplasms | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Chalcone based azacarboline analogues as novel antitubulin agents: design, synthesis, biological evaluation and molecular modelling studies.
Topics: Antineoplastic Agents; Carbolines; Cell Line, Tumor; Chalcone; Chemistry Techniques, Synthetic; Drug Design; Humans; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Tubulin Modulators | 2014 |
Synthesis and biological evaluation of novel millepachine derivatives as a new class of tubulin polymerization inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Multiple; Fluorescent Antibody Technique; Hep G2 Cells; Humans; Mice, Inbred BALB C; Structure-Activity Relationship; Tubulin Modulators; Xenograft Model Antitumor Assays | 2014 |
Notolutesins A-J, dolabrane-type diterpenoids from the Chinese liverwort Notoscyphus lutescens.
Topics: Antineoplastic Agents, Phytogenic; Circular Dichroism; Crystallography, X-Ray; Diterpenes; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Hepatophyta; Humans; Inhibitory Concentration 50; Male; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular | 2014 |
Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents.
Topics: | 2014 |
Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Coumarins; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Polymerization; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured; Wound Healing | 2016 |
Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; Humans; Macrocyclic Compounds; Molecular Docking Simulation; Protein Multimerization; Protein Structure, Quaternary; Structure-Activity Relationship; Tubulin Modulators | 2016 |
Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
Topics: Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Macrocyclic Compounds; Models, Molecular; Molecular Docking Simulation; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2017 |
Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Polymerization; Quinolines; Structure-Activity Relationship; Tubulin | 2017 |
Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors.
Topics: Antineoplastic Agents; Biocatalysis; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Molecular Structure; Polymerization; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tubulin | 2018 |
Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Combinatorial Chemistry Techniques; Humans; Lipopeptides; Neoplastic Stem Cells; Pancreatic Neoplasms; Peptides, Cyclic; Structure-Activity Relationship; Tumor Hypoxia | 2018 |
Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance.
Topics: Animals; Antineoplastic Agents; Carbolines; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Hydrazones; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Structure-Activity Relationship | 2018 |
Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Heterografts; Humans; Indoles; K562 Cells; Neoplasms; Quinolines; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2019 |
Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Naphthoquinones; Oximes; Structure-Activity Relationship; Sulfur | 2019 |
Discovery of lysosome-targeted covalent anticancer agents based on isosteviol skeleton.
Topics: A549 Cells; Antineoplastic Agents; Cell Death; Diterpenes, Kaurane; Drug Design; Humans; Lysosomes; Neoplasms | 2021 |
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Binding Sites; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Design; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neoplasms; Neovascularization, Physiologic; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2021 |
Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chalcones; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Indoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase; Tubulin; Tubulin Modulators | 2022 |
Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Carbolines; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Neoplasms; Protein Binding; Rats; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2022 |
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Paclitaxel | 2022 |
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Ferroptosis; Humans; Microtubules; Neoplasms; Stilbenes | 2022 |